Test bank for focus on nursing pharmacology 7th edition by kar
c c c c c c c c c c
ch all chapters
c c
Advanced Health Assessment (Walden University)
c c c c
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
CognitivecLevel:c ApplicationcDiffic
ulty:c Moderate
IntegratedcProcess:c Nursingcprocess
1.Acnursecworkingcincradiologycadministersciodinectocacpatientcwhocischavingcaccomput
erizedcaxialctomographyc(CAT)cscan.cAcnursecworkingconcanconcologycunitcadministe
rscchemotherapyctocpatientscwhochaveccancer.cAtcthecPubliccHealthcDepartment,cacnur
secadministerscacmeasles-mumps-rubellac(MMR)cvaccinectocac14-cmonth-
oldcchildcascacroutinecimmunization.cWhichcbranchcofcpharmacologycbestcdescribesct
hecactionscofcallcthreecnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Response:
Pharmacologyciscthecstudycofcthecbiologicceffectscofcchemicals.cNursescarecinvolvedcwit
hcclinicalcpharmacologycorcpharmacotherapeutics,cwhichciscacbranchcofcpharmacologyct
hatcdealscwithcthecusescofcdrugsctoctreat,cprevent,candcdiagnosecdisease.cThecnursecworki
ngcincradiologyciscadministeringcacdrugctochelpcdiagnosecacdisease.cThecnursecworkingco
ncanconcologycunitciscadministeringcacdrugctochelpctreatcacdisease.cPharmacoeconomicsci
ncludescanyccostscinvolvedcincdrugctherapy.
Pharmacodynamicscinvolveschowcacdrugcaffectscthecbody,candcpharmacokineticscischow
cthecbodycacts concthecdrug.
CognitivecLevel:c ComprehensioncDi
fficulty:c Easy
IntegratedcProcess:c Nursingcprocess
2.Acphysicianchascorderedcintramuscularcinjectionscofcmorphine,cacnarcotic,ceveryc4chours
cascneededcforcpaincforcacmotorcvehiclecaccidentcvictim.cThecnurseciscawarecthatcthereciscac
highcabusecpotentialcforcthiscdrug;ctherefore,cmorphinecisccategorizedcasca:
A) SchedulecIcdrug
B) SchedulecIIcdrug
C) SchedulecIIIcdrug
D) SchedulecIVcdrug
Ans: B
Response:
NarcoticscsuchcascmorphinecarecconsideredcschedulecIIcdrugscbecausecofcthechighcabusec
potentialcwithcseverecdependencecliability.cSchedulecIcdrugschavechighcabusecpotentialca
ndcnocacceptedcmedicalcuse.cSchedulecIIIcdrugschavecaclessercabusecpotentialcthancsched
ulecIIcdrugscandcancacceptedcmedicalcuse.cSchedulecIVcdrugschaveclowcabusecpotentialca
ndclimitedcdependencecliability.
CognitivecLevel:c Comprehensionc
Difficulty:c Easy
IntegratedcProcess:c Communicationcandcdocumentation
3.AcnursecworkingcforcacdrugccompanyciscinvolvedcincphasecIIIcdrugcevaluationcstudies.c
Whichcofcthecfollowingcmightcthecnursecbecresponsiblecforcduringcthiscstagecofcdrugcdev
elopment?
Pagec1
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
A) Workingcwithcanimalscwhocarecgivencexperimentalcdrugs
B) Monitoringcdrugceffectscincpatientscwhocarecselectedctocparticipatecincacstudy,cwh
ochavecthecdiseasecthatcthecdrugciscmeantctoctreat
C) Collectingcrecordscofcsymptomscthatcparticipantscexperiencecwhilectakingcacdrugc
andcdeterminingcwhetherctheycareccausedcbycthecdiseasecorcthecdrugcInformingche
D) althy,cyoungcvolunteercparticipantscofcpossiblecriskscthatccouldcoccurcfromctaking
cancexperimentalcdrug
Ans: C
Response:
PhasecIIIcstudiescinvolvecusecofcacdrugcincacvastcclinicalcmarketcwherecpatientscarecaskedc
tocrecordcanycsymptomsctheycexperiencecwhilectakingcthecdrugs.cNursescmaycbecrespons
iblecforchelpingccollectcandcanalyzecthecinformationctocbecsharedcwithcthec FoodcandcDru
gcAdministrationc(FDA).cUsecofcanimalscincdrugctestingciscdonecincthecpreclinicalctrials.c
AcselectcgroupcofcpatientscwhocarecinvolvedcincphasecIIcstudiescparticipatecincstudiescwh
erecthecparticipantschavecthecdiseasecthecdrugciscintendedctoctreat.cThesecpatientscarecmo
nitoredccloselycforcdrugceffects.cPhasecIcstudiescinvolvechealthychumancvolunteerscwhoc
arecusuallycpaidcforctheircparticipation.cNursescmaycobservecforcadverseceffectscandctoxi
city.
CognitivecLevel:c ComprehensioncDi
fficulty:c Moderate
IntegratedcProcess:c NursingcProcess
4. Whichcofcthecfollowingcconceptsciscconsideredcwhencgenericcdrugscarecsubstitutedcforcb
rand-namecdrugs?
A) Bioavailability
B) Criticalcconcentration
C) Distribution
D) Half-life
Ans: A
Response:
Bioavailabilityciscthecportioncofcacdosecofcacdrugcthatcreachescthecsystemicccirculationcan
dciscavailablectocactconcbodyccells.cBinderscusedcincacgenericcdrugcmaycnotcbecthecsamecas
cthosecusedcincthecbrand-
namecdrug.cTherefore,cthecwaycthecbodycbreakscdowncandcusescthecdrugcmaycdiffer,cwhi
chcmayceliminatecacsubstitution.cCriticalcconcentrationciscthecamountcofcacdrugcthatciscne
ededctoccausecactherapeuticceffect.
Distributionciscthecphasecofcpharmacokineticscthatcinvolvescthecmovementcofcacdrugctocth
ecbody'sctissues.cAcdrug'schalf-
lifeciscthectimecitctakescforcthecamountcofcdrugctocdecreasectocone-halfcofcthecpeakclevel.
CognitivecLevel:c AnalysiscDifficult
y:c Difficult
IntegratedcProcess:c Teaching/learning
5.Acnurseciscteachingchercpatientcaboutcthecusecofcover-the-
A) counterc(OTC)cdrugs.cWhichcofcthecfollowingcstatementscbestcinformscthecpatientcaboutc
theircsafecuse?
B) “OTCcdrugscarecproductscthatcarecavailablecwithoutcprescriptioncforcself-
ctreatment cofcminorccomplaints.”
“OTCcdrugscarecconsideredcmedicationscandcshouldcbecreportedconcacdrugchistory
.”
Pagec2
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
C) “OTCcdrugscwerecapprovedcascprescriptioncdrugscbutclatercwerecfoundctocbecsafec
withoutcthecneedcforcacprescription.”
D) “OTCcdrugscneedctocbectakencwithccaution.cTheyccancmaskcthecsignscandcsympto
mscofcancunderlyingcdiseasecandcinterferecwithcprescriptioncdrugctherapy.”
D
Ans: Response:
OTCcdrugscarecconsideredcmedicationscandcshouldcbecreported.cOTCcdrugscarecavailabl
ecwithoutcacprescription,calthoughcsomecwerecfirstcapprovedcascprescriptioncdrugs.cThec
mostcimportantcteachingcshouldcrelatectoctheircsafecusecandcthatcOTCcdrugsccancmaskcsy
mptomscofcdiseasecandcinterferecwithcprescribedcdrugs.
CognitivecLevel:c KnowledgecDifficu
lty:c Easy
IntegratedcProcess:c NursingcProcess
6. WhichcofcthecfollowingclegislativecactscallowedcthecFoodcandcDrugcAdministrationc(
FDA)ctoctightenccontrolcovercthecqualitycofcdrugscandcrequiredcthatcsafetycandcefficac
ycstandardscbecestablished?
A) PurecFoodcandcDrugcActcofc1906
B) FederalcFood,cDrug,candcCosmeticcActcofc1938
C) DurhamcHumphreycAmendmentcofc1951
D) Kefauver-HarriscActcofc1962
Ans: D
Response:
ThecKefauver-
HarriscActcwascthecresultcofcthecusecofcthec1960scdrugcthalidomidec(Thalomid).cThecpub
liccconcerncledctoctheclegislationcthatcgavecthecFDAcregulatoryccontrolcoverctestingcandc
evaluatingcofcdrugscandcallowedcitctocsetcstandardscforcefficacycandcsafety.cThecPurecFo
odcandcDrugcActcrequiredclabelingctoceliminatecfalsecclaims.cThecFederalcFood,cDrug,ca
ndcCosmeticcActcgavecthecFDActhecpowerctocenforcecstandardscforctestingcdrugctoxicity
candcmonitoringclabeling.cThecDurham-
cHumphreycAmendmentcenforcedcprescriptionscforcdistribution.
CognitivecLevel:c ApplicationcDiffic
ulty:c Moderate
IntegratedcProcess:c Teaching/learning
7. Acnurseciscinstructingcacpregnantcpatientcconcerningcthecpotentialcriskctochercfetuscfr
omcacpregnancyccategorycBcdrug.cThecnursecwouldcinformcthecpatientcthat:
A) “Adequatecstudiescincpregnantcwomenchavecdemonstratedcthereciscnocriskctocthecfe
tus.”
B) “Animalcstudieschavecnotcdemonstratedcacriskctocthecfetuscbutctherechavecbeencn
ocadequatecstudiescincpregnantcwomen.”
C) “Animalcstudieschavecshowncancadverseceffectconcthecfetuscbutctherecarecnoca
dequatecstudiescincpregnantcwomen.”
D) “Thereciscevidencecofchumancfetalcriskcbutcthecpotentialcbenefitscfromcusecofcthecdr
ugcmaycbecacceptablecdespitecpotentialcrisks.”
Ans: B
Response:
CategorycBcindicatescthatcanimalcstudieschavecnotcdemonstratedcacriskctocthecfetuscbut
Pagec3
c c c c c c c c c c
ch all chapters
c c
Advanced Health Assessment (Walden University)
c c c c
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
CognitivecLevel:c ApplicationcDiffic
ulty:c Moderate
IntegratedcProcess:c Nursingcprocess
1.Acnursecworkingcincradiologycadministersciodinectocacpatientcwhocischavingcaccomput
erizedcaxialctomographyc(CAT)cscan.cAcnursecworkingconcanconcologycunitcadministe
rscchemotherapyctocpatientscwhochaveccancer.cAtcthecPubliccHealthcDepartment,cacnur
secadministerscacmeasles-mumps-rubellac(MMR)cvaccinectocac14-cmonth-
oldcchildcascacroutinecimmunization.cWhichcbranchcofcpharmacologycbestcdescribesct
hecactionscofcallcthreecnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Response:
Pharmacologyciscthecstudycofcthecbiologicceffectscofcchemicals.cNursescarecinvolvedcwit
hcclinicalcpharmacologycorcpharmacotherapeutics,cwhichciscacbranchcofcpharmacologyct
hatcdealscwithcthecusescofcdrugsctoctreat,cprevent,candcdiagnosecdisease.cThecnursecworki
ngcincradiologyciscadministeringcacdrugctochelpcdiagnosecacdisease.cThecnursecworkingco
ncanconcologycunitciscadministeringcacdrugctochelpctreatcacdisease.cPharmacoeconomicsci
ncludescanyccostscinvolvedcincdrugctherapy.
Pharmacodynamicscinvolveschowcacdrugcaffectscthecbody,candcpharmacokineticscischow
cthecbodycacts concthecdrug.
CognitivecLevel:c ComprehensioncDi
fficulty:c Easy
IntegratedcProcess:c Nursingcprocess
2.Acphysicianchascorderedcintramuscularcinjectionscofcmorphine,cacnarcotic,ceveryc4chours
cascneededcforcpaincforcacmotorcvehiclecaccidentcvictim.cThecnurseciscawarecthatcthereciscac
highcabusecpotentialcforcthiscdrug;ctherefore,cmorphinecisccategorizedcasca:
A) SchedulecIcdrug
B) SchedulecIIcdrug
C) SchedulecIIIcdrug
D) SchedulecIVcdrug
Ans: B
Response:
NarcoticscsuchcascmorphinecarecconsideredcschedulecIIcdrugscbecausecofcthechighcabusec
potentialcwithcseverecdependencecliability.cSchedulecIcdrugschavechighcabusecpotentialca
ndcnocacceptedcmedicalcuse.cSchedulecIIIcdrugschavecaclessercabusecpotentialcthancsched
ulecIIcdrugscandcancacceptedcmedicalcuse.cSchedulecIVcdrugschaveclowcabusecpotentialca
ndclimitedcdependencecliability.
CognitivecLevel:c Comprehensionc
Difficulty:c Easy
IntegratedcProcess:c Communicationcandcdocumentation
3.AcnursecworkingcforcacdrugccompanyciscinvolvedcincphasecIIIcdrugcevaluationcstudies.c
Whichcofcthecfollowingcmightcthecnursecbecresponsiblecforcduringcthiscstagecofcdrugcdev
elopment?
Pagec1
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
A) Workingcwithcanimalscwhocarecgivencexperimentalcdrugs
B) Monitoringcdrugceffectscincpatientscwhocarecselectedctocparticipatecincacstudy,cwh
ochavecthecdiseasecthatcthecdrugciscmeantctoctreat
C) Collectingcrecordscofcsymptomscthatcparticipantscexperiencecwhilectakingcacdrugc
andcdeterminingcwhetherctheycareccausedcbycthecdiseasecorcthecdrugcInformingche
D) althy,cyoungcvolunteercparticipantscofcpossiblecriskscthatccouldcoccurcfromctaking
cancexperimentalcdrug
Ans: C
Response:
PhasecIIIcstudiescinvolvecusecofcacdrugcincacvastcclinicalcmarketcwherecpatientscarecaskedc
tocrecordcanycsymptomsctheycexperiencecwhilectakingcthecdrugs.cNursescmaycbecrespons
iblecforchelpingccollectcandcanalyzecthecinformationctocbecsharedcwithcthec FoodcandcDru
gcAdministrationc(FDA).cUsecofcanimalscincdrugctestingciscdonecincthecpreclinicalctrials.c
AcselectcgroupcofcpatientscwhocarecinvolvedcincphasecIIcstudiescparticipatecincstudiescwh
erecthecparticipantschavecthecdiseasecthecdrugciscintendedctoctreat.cThesecpatientscarecmo
nitoredccloselycforcdrugceffects.cPhasecIcstudiescinvolvechealthychumancvolunteerscwhoc
arecusuallycpaidcforctheircparticipation.cNursescmaycobservecforcadverseceffectscandctoxi
city.
CognitivecLevel:c ComprehensioncDi
fficulty:c Moderate
IntegratedcProcess:c NursingcProcess
4. Whichcofcthecfollowingcconceptsciscconsideredcwhencgenericcdrugscarecsubstitutedcforcb
rand-namecdrugs?
A) Bioavailability
B) Criticalcconcentration
C) Distribution
D) Half-life
Ans: A
Response:
Bioavailabilityciscthecportioncofcacdosecofcacdrugcthatcreachescthecsystemicccirculationcan
dciscavailablectocactconcbodyccells.cBinderscusedcincacgenericcdrugcmaycnotcbecthecsamecas
cthosecusedcincthecbrand-
namecdrug.cTherefore,cthecwaycthecbodycbreakscdowncandcusescthecdrugcmaycdiffer,cwhi
chcmayceliminatecacsubstitution.cCriticalcconcentrationciscthecamountcofcacdrugcthatciscne
ededctoccausecactherapeuticceffect.
Distributionciscthecphasecofcpharmacokineticscthatcinvolvescthecmovementcofcacdrugctocth
ecbody'sctissues.cAcdrug'schalf-
lifeciscthectimecitctakescforcthecamountcofcdrugctocdecreasectocone-halfcofcthecpeakclevel.
CognitivecLevel:c AnalysiscDifficult
y:c Difficult
IntegratedcProcess:c Teaching/learning
5.Acnurseciscteachingchercpatientcaboutcthecusecofcover-the-
A) counterc(OTC)cdrugs.cWhichcofcthecfollowingcstatementscbestcinformscthecpatientcaboutc
theircsafecuse?
B) “OTCcdrugscarecproductscthatcarecavailablecwithoutcprescriptioncforcself-
ctreatment cofcminorccomplaints.”
“OTCcdrugscarecconsideredcmedicationscandcshouldcbecreportedconcacdrugchistory
.”
Pagec2
, TestcBankcforcFocuscOncNursingcPharmacologyc7thcEditio
n
Chapterc1:cIntroductionctocDrugs
C) “OTCcdrugscwerecapprovedcascprescriptioncdrugscbutclatercwerecfoundctocbecsafec
withoutcthecneedcforcacprescription.”
D) “OTCcdrugscneedctocbectakencwithccaution.cTheyccancmaskcthecsignscandcsympto
mscofcancunderlyingcdiseasecandcinterferecwithcprescriptioncdrugctherapy.”
D
Ans: Response:
OTCcdrugscarecconsideredcmedicationscandcshouldcbecreported.cOTCcdrugscarecavailabl
ecwithoutcacprescription,calthoughcsomecwerecfirstcapprovedcascprescriptioncdrugs.cThec
mostcimportantcteachingcshouldcrelatectoctheircsafecusecandcthatcOTCcdrugsccancmaskcsy
mptomscofcdiseasecandcinterferecwithcprescribedcdrugs.
CognitivecLevel:c KnowledgecDifficu
lty:c Easy
IntegratedcProcess:c NursingcProcess
6. WhichcofcthecfollowingclegislativecactscallowedcthecFoodcandcDrugcAdministrationc(
FDA)ctoctightenccontrolcovercthecqualitycofcdrugscandcrequiredcthatcsafetycandcefficac
ycstandardscbecestablished?
A) PurecFoodcandcDrugcActcofc1906
B) FederalcFood,cDrug,candcCosmeticcActcofc1938
C) DurhamcHumphreycAmendmentcofc1951
D) Kefauver-HarriscActcofc1962
Ans: D
Response:
ThecKefauver-
HarriscActcwascthecresultcofcthecusecofcthec1960scdrugcthalidomidec(Thalomid).cThecpub
liccconcerncledctoctheclegislationcthatcgavecthecFDAcregulatoryccontrolcoverctestingcandc
evaluatingcofcdrugscandcallowedcitctocsetcstandardscforcefficacycandcsafety.cThecPurecFo
odcandcDrugcActcrequiredclabelingctoceliminatecfalsecclaims.cThecFederalcFood,cDrug,ca
ndcCosmeticcActcgavecthecFDActhecpowerctocenforcecstandardscforctestingcdrugctoxicity
candcmonitoringclabeling.cThecDurham-
cHumphreycAmendmentcenforcedcprescriptionscforcdistribution.
CognitivecLevel:c ApplicationcDiffic
ulty:c Moderate
IntegratedcProcess:c Teaching/learning
7. Acnurseciscinstructingcacpregnantcpatientcconcerningcthecpotentialcriskctochercfetuscfr
omcacpregnancyccategorycBcdrug.cThecnursecwouldcinformcthecpatientcthat:
A) “Adequatecstudiescincpregnantcwomenchavecdemonstratedcthereciscnocriskctocthecfe
tus.”
B) “Animalcstudieschavecnotcdemonstratedcacriskctocthecfetuscbutctherechavecbeencn
ocadequatecstudiescincpregnantcwomen.”
C) “Animalcstudieschavecshowncancadverseceffectconcthecfetuscbutctherecarecnoca
dequatecstudiescincpregnantcwomen.”
D) “Thereciscevidencecofchumancfetalcriskcbutcthecpotentialcbenefitscfromcusecofcthecdr
ugcmaycbecacceptablecdespitecpotentialcrisks.”
Ans: B
Response:
CategorycBcindicatescthatcanimalcstudieschavecnotcdemonstratedcacriskctocthecfetuscbut
Pagec3
